# Precision fermentation Genetically engineered microbes as cell factories for proteins, enzymes, HMOs and flavors — a stack from strain design to purified ingredient, at 30–50 g/L target titers. Source: https://en.bioecon.ru/technology/precision-fermentation/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: EU Novel Food Regulation | OECD: Food Systems | Regulator: FDA (USA), EFSA (EU), NMPA (China)] Precision fermentation uses genetically engineered microbes — yeast, filamentous fungi and bacteria — as cell factories for specific high-value molecules: dairy and egg proteins, HMOs, industrial enzymes, vitamins and flavors. Optimized strains reach 30–50 g/L of target product at >90% purity, and the cost of alternative proteins is falling on a trajectory from $10–20/kg (2020) toward a target of $3–6/kg. Versus animal agriculture the technology cuts land use by 95%, water use by 90% and greenhouse-gas emissions by 80%. The synergy is the pairing of a designed strain with a tuned upstream-downstream process and real-time PAT analytics. Key directions of precision fermentation: 1. **Animal-free dairy proteins (Animal-Free Dairy Proteins):** β-lactoglobulin and casein secreted by engineered yeast and fungi. 2. **Egg proteins (Egg Proteins):** ovalbumin for baking and foaming (FDA GRAS since 2023). 3. **HMOs and bioactives (HMOs & Bioactives):** 2'-fucosyllactose and lacto-N-neotetraose for infant nutrition. 4. **Industrial enzymes and flavors (Enzymes & Flavours):** proteases, lipases, vanillin and terpenes via precision-fermentation strains. ### Sectoral value chain ``` [strain design] ──> [fermentation] ──> [harvest] ──> [purification] │ (cell factory) │ ▼ [ingredient] <─── [drying/formulation] <─────┘ ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Strain Design** | host selection and pathway engineering (CRISPR, metabolic modeling) | **In:** host, DNA. **Out:** production strain. | | **Upstream Fermentation** | cell-factory cultivation (fed-batch/continuous) | **In:** sugar, media, air. **Out:** fermentation broth. | | **Harvest** | cell separation and clarification | **In:** broth. **Out:** clarified liquor. | | **Downstream Purification** | chromatography and TFF; in the EU — GMM-DNA clearance | **In:** liquor. **Out:** purified molecule. | | **Drying & Formulation** | spray-drying and standardization | **In:** purified stream. **Out:** ingredient powder. | | **Application & B2B Sale** | integration into food, nutrition and consumer goods | **In:** ingredient. **Out:** product. | Cross-cutting technologies of the sector: - **Strain engineering (Strain Engineering):** CRISPR rewiring of hosts (S. cerevisiae, Pichia, Trichoderma, Corynebacterium) for 5–10× titer gains. - **Microbial platforms (Microbial Platforms):** yeast (proteins, flavors), fungi (enzymes), bacteria (amino acids, vitamins). - **Process analytical technology (PAT):** inline spectroscopy (Raman, NIR) driving feed and induction. --- ## US The US is the technology leader: >200 companies, a 4.5B market (2024),8+B of VC (2019–2024), and the FDA GRAS route. ### FDA GRAS pathway, alt-protein venture cluster, USDA/NSF scale-up funding - **FDA GRAS:** voluntary GRAS notification for precision-fermentation ingredients (15+ clearances). - **Perfect Day:** the world's first commercial animal-free whey (Trichoderma), partnering with General Mills. - **New Culture:** animal-free casein mozzarella built on microbial casein, targeting pizzeria melt performance. - **Checkerspot:** diversifies precision fermentation beyond food into microalgal-derived specialty oils and biopolymers (Algenesis thermoplastic polyurethanes). - **USDA ARS + NSF Future Manufacturing:** $150M/year toward biomanufacturing scale-up. --- ## CN China bets on scale and food security: $6B committed in the 14th Five-Year Plan for biomanufacturing (2021–2025). ### 14th Five-Year Plan, amino-acid & enzyme scale, alternative-protein pilots - **Angel Yeast (Yichang):** $500M expansion,50,000 t of alternative proteins. - **Phycon Biotech (Shanghai):** 5,000 t/year dairy-protein pilot, $4/kg target price. - **Meihua/BBCA:** global leaders in amino acids and organic acids via fermentation. --- ## EU The EU is strong in designer food proteins and enzymes, but constrained by an acute shortage of pilot bioreactor capacity and the Novel Food regime. ### Novel Food & EFSA, CMO capacity bottleneck, designer dairy proteins - **EU Novel Food (EC 2015/2283):** EFSA approval plus mandatory GMM-DNA clearance. - **Formo (Berlin):** synthetic casein/whey from Trichoderma, cheeses in REWE, -96% carbon footprint. - **Remilk (Israel/Denmark):** microbial dairy proteins produced at its Kalundborg, Denmark facility, with FDA GRAS clearance. - **Better Dairy (UK):** London-based precision-fermentation cheese maker producing animal-free casein. - **CMO platforms:** BBEPP (Belgium) and TWB (France) rent bioreactors to startups. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Perfect Day** | 🇺🇸 USA | *dairy whey (β-lactoglobulin)* | Trichoderma, GRAS | Commercial | | **Motif FoodWorks** | 🇺🇸 USA | *heme protein (HEMAMI™)* | mRNA in yeast | discontinued (wound down Sept 2024; heme business sold to Impossible Foods) | | **Formo** | 🇩🇪 Germany | *animal-free casein/whey* | Trichoderma, cheeses | Scaling | | **Angel Yeast** | 🇨🇳 China | *yeast proteins, enzymes* | 100,000 t/year | Commercial | | **Phycon Biotech** | 🇨🇳 China | *dairy proteins* | 5,000 t/year pilot | Pilot | | **Novonesis** | 🇩🇰 Denmark | *enzymes, food cultures* | Novozymes+Chr. Hansen merger | Commercial | | **New Culture** | 🇺🇸 USA | *animal-free casein mozzarella* | microbial casein | Scaling | | **Remilk** | 🇮🇱 Israel | *dairy proteins* | Kalundborg Denmark facility; GRAS | Commercial | | **Better Dairy** | 🇬🇧 UK | *animal-free cheese* | precision-ferm casein | Scaling | | **Checkerspot** | 🇺🇸 USA | *precision-ferm oils & polymers* | microalgal oil platform | Commercial | --- ## Tech stack and innovations The stack binds a designed strain to an instrumented process with PAT control. 1. **Yeast platform (Yeast Platform):** - S. cerevisiae and Pichia pastoris for proteins and flavors, at 30–50 g/L. - case: Perfect Day — the first commercial precision-fermentation whey. 2. **Filamentous fungi (Filamentous Fungi):** - Trichoderma/Aspergillus for enzyme and protein secretion. - case: Formo — Trichoderma casein for meltable cheeses. 3. **Bacterial platforms (Bacterial Platforms):** - Corynebacterium/E. coli for amino acids and vitamins with fast growth. --- ## Value chains and production pipelines ### Industrial pipeline of a precision-fermentation ingredient (ISO 22000 / GMP) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Strain build │ ───> │ 2. Seed train │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Purification (GMM too) │ <─── │ 3. Fermentation │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Drying & formulation │ ───> │ 6. B2B application │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Strain build A host is reprogrammed (CRISPR, synthetic biology) to secrete the target molecule at 30–50 g/L titer. #### Stage 2: Seed train A cell bank is expanded through staged seed bioreactors to production volume. #### Stage 3: Fermentation Fed-batch or continuous runs convert sugar feedstock into product broth under PAT control. #### Stage 4: Purification Chromatography and TFF isolate the molecule to >90% purity; in the EU, GMM-DNA clearance is mandatory. #### Stage 5: Drying & formulation Spray-drying yields a standardized ingredient powder. #### Stage 6: B2B application The ingredient enters food, beverage, nutrition and cosmetic products.